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constructing a CRITICAL PATH FOR PRODUCT
DEVELOPMENT, COMMERCIALIZATION, AND ACCESS
Martha Brady, Senior Associate

The Population Council is an international nonprofit,
nongovernmental organization that conducts biomedical, social science, and public health research
on HIV and AIDS; poverty, gender and youth; and
reproductive health (RH). Our work cuts across disciplines, geographies, and the public and private sectors. The Population Council develops and tests the
effectiveness and acceptability of new and improved
health technologies, including contraceptives and
microbicides, which are designed to benefit women
and men in developing countries. Our work includes
user’s perspectives throughout the development
and introduction process. In addition, we encourage
licensing, registration, manufacturing, and distribution
of contraceptive and other RH technologies developed by the Council.
Council’s work on product development
The Population Council has developed and licensed some of
the most widely used long-acting, reversible contraceptives in
the world. Our work includes basic research directed toward
fundamental understanding of biology and disease processes,
providing the foundation for product development, as well
as translational research which employs novel techniques and
tools in the lab, and innovative approaches in field programs to
ensure that our scientific discoveries translate into improving
the lives of women and men around the globe.
As a product developer we know what is required to take
an innovation to a viable product. Product developers must
negotiate scientific and technical dimensions along the critical
path from innovation to commercial product. Whether working with drugs, devices, or biologics—or some combination
thereof—our experience suggests that this pathway encompasses scientific, technical, programmatic and policy dimensions.

Assessing
safety

Licensing/
distribution,
market
development

Demonstrating
medical and/or
public health
utility

Ensuring
regulatory
approval

Industrialization/
manufacturing

Procurement/
financing
Demand
generation

Enabling
policies

Scaling
up

Brady, M., Critical Path Framework, ©2011 Population Council.

The critical path
The focus of the FDA’s Critical Path initiative includes:
• Assessing safety.
• Demonstrating medical and/or public health utility.
• Industrialization.
Equally important elements in delivering the product to the
user include:
• Ensuring regulatory approval.
• Establishing licensing and distribution channels.
• Seeding and developing markets.
• Negotiating financing and procurement mechanisms.
• Generating demand among potential users, providers,
and policymakers.
• Developing service delivery guidelines and training.
• Creating an enabling policy environment.
• Planning for scaling up.
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Scientific, Technical, Programmatic, and Policy Dimensions of A Critical Path
Dimension
Assessing safety*

Definition
Show that the product is
adequately safe for each
stage of development

Illustrative Activities
• Pre-clinical
 Show that product is safe enough for human testing
 Eliminate products with safety problems
• Clinical
 Show that product is safe enough for use in humans
 Identify potential issues with labeling

Demonstrating
medical and/or
public health utility*

Show that the product
benefits people who will
eventually use it

• Pre-clinical: Select appropriate design (devices) or
candidate (drugs) with high probability of effectiveness

Industrialization/
manufacturing*

From lab concept or
prototype to a reliably
manufactured product

• Design a high-quality product: physical design,
characterization, specifications

Ensuring regulatory
approval

Approval of product by
regulatory authorities
(e.g., FDA, EMA, SRAs)

• Determine regulatory pathway; engage regulatory bodies

Licensing/distribution,
market development

Establish licensing
arrangements

• Identify suitable licensing and distribution entities

• Clinical
 Show effectiveness in people
 Evaluate acceptability among users

• Develop production capacity for:
 Manufacturing scale-up
 Quality control
 Transfer of technology

• Work with manufacturer to submit dossiers

• Conduct market seeding activities
• Strengthen supply chain

Procurement/
financing

Mechanism for bulk
purchasing and financing

• Establish public sector pricing and financing arrangements
• Engage donors around procurement
• Conduct strategic demand forecasting

Demand generation

Transform unmet need
into user demand

• Create awareness among users, providers, and
policymakers
• Engage advocacy, civil society, and women’s groups
• Identify market segments, advertising and pricing strategies
• Document user perspective

Fostering an enabling
policy environment

Incorporate into
international guidelines
and national norms

• Issue WHO guidelines
• Develop country service delivery protocols
• Identify and train providers and key opinion leaders
• Conduct implementation research to identify best ways to
expand access and improve quality

Scaling up

Take product to
mainstream

• Prepare introduction strategy with local stakeholders
• Assess acceptability under routine service conditions
• Conduct implementation research and measure and
evaluation

